Pucotenlimab
Undisclosed (PD-1 antibody)
CommercialApproved (S20220022)
Key Facts
Indication
Undisclosed (PD-1 antibody)
Phase
Commercial
Status
Approved (S20220022)
Company
About HanX Biopharmaceuticals
Clinical-stage Chinese biotech developing novel antibody therapies for oncology and immunology with multiple IND approvals.
View full company profile